Company Profile

SUVEN PHARMACEUTICALS LTD.

NSE : SUVENPHARBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE530.90-32.15 (-5.71 % )
PREV CLOSE (Rs.) 563.05
OPEN PRICE (Rs.) 567.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 54968
TODAY'S LOW / HIGH (Rs.)526.75 567.00
52 WK LOW / HIGH (Rs.)292 574.45
NSE532.35 -30.65 (-5.44 % )
PREV CLOSE(Rs.) 563.00
OPEN PRICE (Rs.) 564.80
BID PRICE (QTY) 532.35 (203 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 467876
TODAY'S LOW / HIGH(Rs.) 528.50 567.30
52 WK LOW / HIGH (Rs.)291.6 574.5

Financial ratio

Particulars Mar  2020 Mar  2019
Operational & Financial Ratios    
   Earnings Per Share (Rs) 24.91 0.00
   CEPS(Rs) 11.50 NA
   DPS(Rs) 5.00 0.00
   Book NAV/Share(Rs) 66.37 NA
   Tax Rate(%) 24.56 30.78
Margin Ratios    
   Core EBITDA Margin(%) 46.19 45.40
   EBIT Margin(%) 45.50 42.52
   Pre Tax Margin(%) 42.73 41.78
   PAT Margin (%) 32.24 28.92
   Cash Profit Margin (%) 35.10 31.96
Performance Ratios    
   ROA(%) 25.50 13.39
   ROE(%) 37.80 18.92
   ROCE(%) 44.55 23.87
   Asset Turnover(x) 0.79 0.46
   Sales/Fixed Asset(x) 2.07 1.09
   Working Capital/Sales(x) 4.36 1.63
Efficiency Ratios    
   Fixed Capital/Sales(x) 0.48 0.92
   Receivable days 57.94 142.49
   Inventory Days 72.66 151.76
   Payable days 49.88 86.75
Valuation Parameters    
   PER(x) 4.04 NA
   PCE(x) 8.76 NA
   Price/Book(x) 3.04 NA
   Yield(%) 2.48 NA
   EV/Net Sales(x) 3.28 NA
   EV/Core EBITDA(x) 6.78 NA
   EV/EBIT(x) 7.21 NA
   EV/CE(x) 2.12 NA
   M Cap / Sales 3.08 NA
Growth Ratio    
   Net Sales Growth(%) 120.68 0.00
   Core EBITDA Growth(%) 134.23 0.00
   EBIT Growth(%) 136.13 0.00
   PAT Growth(%) 145.98 0.00
   EPS Growth(%) NA NA
Financial Stability Ratios    
   Total Debt/Equity(x) 0.22 0.14
   Current Ratio(x) 1.60 2.22
   Quick Ratio(x) 1.05 1.39
   Interest Cover(x) 16.45 57.60
   Total Debt/Mcap(x) 0.07 NA